Several recent studies on the mTOR signaling pathway have identified it as an important regulatory target for the treatment of the epidermal and functional structure in dermatologic diseases, including psoriasis, and relatedly, there are reports that natural products that can modulate this signaling pathway have shown good efficacy in ameliorating animal models of psoriasis with dyslipidemia [243,244]. Here, MTOR is linked to metabolic syndrome.